FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used for prediction of risk of unfavorable outcome in patients with ischemic heart disease within a year after coronary artery bypass. Patients with ischemic heart disease on the first day of admission to hospital, prior to coronary artery bypass grafting, by flow cytofluorometry, phenotyping TLR9 in peripheral blood monocytes, %, using monoclonal antibodies. A prognostic coefficient K is calculated by formula: K = exp (-11.7 + 0.15 * x)/(1 + exp (-11.7 + 0.15) * x)), where K is a prognostic coefficient reflecting a probability of developing a negative cardiovascular event, and x is a value of the initial expression of TLR9 by monocytes, %. Constant value 11.7 and coefficient 0.15 before variable x are obtained by logistic regression by experimental method. At value K ≥ 0.639 predict a high risk of developing a negative cardiovascular event in the year following coronary artery bypass grafting. If K < 0.639, the risk of developing a negative cardiovascular event is low.
EFFECT: method provides predicting a risk of developing a negative cardiovascular event in patients with ischemic heart disease within the year following coronary artery bypass grafting due to patient's phenotyping TLR9 in peripheral blood monocytes using monoclonal antibodies and calculating prognostic coefficient by formula obtained by logistic regression method.
1 cl, 2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF AN UNFAVORABLE OUTCOME IN PATIENTS WITH ISCHEMIC HEART DISEASE WHO UNDERWENT AORTOCORONARY BYPASS SURGERY | 2018 |
|
RU2688241C1 |
METHOD FOR STENT RESTENOSIS PREDICTION IN PATIENTS WITH ISCHEMIC HEART DISEASE 6 MONTHS AFTER CORONARY STENTING | 2019 |
|
RU2695782C1 |
METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE OUTCOME IN PATIENTS WITH ACUTE CORONARY SYNDROME AND CONCOMITANT TYPE 2 DIABETES MELLITUS | 2014 |
|
RU2573499C1 |
METHOD OF PREDICTING THE RISK OF DEVELOPING ADVERSE CARDIOVASCULAR OUTCOMES WITHIN A YEAR AFTER PERCUTANEOUS CORONARY INTERVENTIONS WITH STENTING IN PATIENTS WITH STABLE CORONARY HEART DISEASE | 2022 |
|
RU2799146C1 |
METHOD FOR PREDICTION OF CARDIOVASCULAR COMPLICATIONS FOLLOWING CORONARY BYPASS SURGERY IN PATIENTS WITH ISCHEMIC HEART DISEASES | 2014 |
|
RU2571715C1 |
METHOD FOR ASSESSING THE RISK OF DEVELOPING ADVERSE OUTCOMES WITHIN THE FIRST YEAR FOLLOWING THE PERCUTANEOUS CORONARY INTERVENTION WITH STENTING IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE | 2018 |
|
RU2692257C1 |
METHOD OF PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ETIOLOGY WITHIN A YEAR AFTER CORONARY ARTERY BYPASS GRAFTING | 2022 |
|
RU2801160C1 |
METHOD OF PREDICTING PROBABILITY OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE WHO HAVE UNDERGONE PLANNED CORONARY MYOCARDIAL REVASCULARIZATION | 2023 |
|
RU2814112C1 |
METHOD FOR DETERMINING INDICATIONS TO SURGICAL TREATMENT OF CARDIAC ISCHEMIA PATIENTS SURVIVED AFTER MYOCARDIAL INFARCTION | 2004 |
|
RU2269934C1 |
METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE CARDIOVASCULAR EVENTS IN PATIENTS SUFFERING ISCHEMIC HEART DISEASE WITH ISCHEMIC AND/OR POSTINFARCTION MYOCARDIAL DYSFUNCTION ACCOMPANYING CHRONIC CARDIAL INSUFFICIENCY | 2014 |
|
RU2568577C1 |
Authors
Dates
2019-10-31—Published
2019-01-24—Filed